ProMIS Neurosciences, Inc. (PMN)
R&D to Revenue
0.00%
Quarterly · Period ending:
PMN R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
PMN Quarterly R&D/Revenue (16148.30% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
PMN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -205,610.5225% | |
| 0% | |
| 0% | |
| 46,273.5889% | |
| 73,129.9831% | |
| 15,699.6491% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 57,436.869% | |
| 0% | |
| 72,289.7671% | |
| 12,673,857.0671% | |
| 5,474,995.7281% | |
| -4,847,788.5785% | |
| 719,000% | |
| 710,131.9267% | |
| 0% | |
| 13,960,116.6092% | |
| 212,598.69% | |
| 11,036.7451% | |
| 2,326,405.6793% | |
| 84,407.1429% | |
| 343,867.3171% | |
| 0% | |
| 0% | |
| 11,202.0917% | |
| -22,634.0426% | |
| 3,548.0047% | |
| 10,776.247% | |
| 1,607.7018% | |
| 641.0493% | |
| 649.7854% | |
| 372.1502% | |
| 661.5953% | |
| 831.2221% | |
| 1,303.7487% | |
| 1,238.279% | |
| 1,407.885% | |
| 2,679.3676% | |
| 58,890.781% | |
| 27,960.2833% | |
| 27.1334% | |
| 3,127.2617% | |
| 44.526% | |
| 1,265.7324% | |
| 1,049.3842% | |
| 6,062.9803% | |
| 64.1612% | |
| 6,340.1383% | |
| 2,963.6526% | |
| 1,310.49% | |
| 2,555.2685% | |
| 2,132.0613% | |
| 1,944.1781% | |
| 1,484.8586% | |
| 1,521.6026% | |
| 1,802.0557% | |
| 1,644.9298% | |
| 11,487.2225% | |
| 1,337.2047% | |
| 1,134.4836% | |
| 1,715.472% | |
| 1,056.4175% | |
| 1,152.2221% | |
| 1,300.346% | |
| 2,581.6285% | |
| 1,949.7776% | |
| 10,129.6601% | |
| 16,148.3023% |